A borderline significant reduction in pain intensity has been demonstrated. 140 Topical clonidine (0.1% gel) has been evaluated in a Phase II, double-blind RCT in 166 subjects with DPN.
1
—
—
A borderline significant reduction in pain intensity has been demonstrated. 140 Topical clonidine (0.1% gel) has been evaluated in a Phase II, double-blind RCT in 166 subjects with DPN.